SINEMET - 0056-0521-68 - (CARBIDOPA AND LEVODOPA)

Alphabetical Index


Drug Information of SINEMET

Product NDC: 0056-0521
Proprietary Name: SINEMET
Non Proprietary Name: CARBIDOPA AND LEVODOPA
Active Ingredient(s): 50; 200    mg/1; mg/1 & nbsp;   CARBIDOPA AND LEVODOPA
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of SINEMET

Product NDC: 0056-0521
Labeler Name: Bristol-Myers Squibb Pharma Company
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA019856
Marketing Category: NDA
Start Marketing Date: 20090601

Package Information of SINEMET

Package NDC: 0056-0521-68
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0056-0521-68)

NDC Information of SINEMET

NDC Code 0056-0521-68
Proprietary Name SINEMET
Package Description 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0056-0521-68)
Product NDC 0056-0521
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name CARBIDOPA AND LEVODOPA
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20090601
Marketing Category Name NDA
Labeler Name Bristol-Myers Squibb Pharma Company
Substance Name CARBIDOPA; LEVODOPA
Strength Number 50; 200
Strength Unit mg/1; mg/1
Pharmaceutical Classes Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA]

Complete Information of SINEMET


General Information